polycythemia vera - HEALTHIES
The American Journal of Managed Care: Update: Ruxolitinib Beats Best Available Therapy in Treating Polycythemia Vera Ruxolitinib improves hematocrit control and treatment response in polycythemia vera compared to best available therapy. Patients on ruxolitinib show better Myeloproliferative Neoplasms-Symptom ... The American Journal of Managed Care: Rusfertide Poised to Transform Polycythemia Vera Care: Andrew Kuykendall, MD A review of management strategies for patients with polycythemia vera and myelofibrosis was presented at the 2026 ONA Summit.
Understanding the Context
Monthly Prescribing Reference: Hepcidin Mimetic Rusfertide Gets Priority Review for Polycythemia Vera techtimes: New Drug Rusfertide Shows Promise in Treating Polycythemia Vera, Revealing Positive Outcomes A breakthrough in the treatment of polycythemia vera, a rare and life-threatening blood cancer, has emerged with the introduction of a new drug named rusfertide. Polycythemia vera falls under the ... New Drug Rusfertide Shows Promise in Treating Polycythemia Vera, Revealing Positive Outcomes CHICAGO -- The use of the investigational weekly subcutaneous injection rusfertide significantly reduced the need for phlebotomy among polycythemia vera patients who had been dependent on it, the ... Learn about Polycythemia Vera, a rare blood disorder, its symptoms, risk factors, complications, and how early diagnosis and treatment can help manage the condition effectively.
Image Gallery
Key Insights
Monthly Prescribing Reference: Rusfertide Improves Hematocrit Control in Patients With Polycythemia Vera Rusfertide showed a 77% clinical response rate in polycythemia vera patients, significantly higher than the 33% with placebo. The drug reduced phlebotomy frequency, with 0.5 per patient in the ... A panelist discusses how patients should communicate comprehensively with their care team about symptom patterns, documentation methods, and warning signs of polycythemia vera progression, including ...